Evolent Health Inc
NYSE:EVH
Intrinsic Value
Evolent Health, Inc. engages in the provision of health care delivery and payment services. [ Read More ]
The intrinsic value of one EVH stock under the Base Case scenario is 34.58 USD. Compared to the current market price of 28.32 USD, Evolent Health Inc is Undervalued by 18%.
Valuation Backtest
Evolent Health Inc
Run backtest to discover the historical profit from buying and selling EVH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Evolent Health Inc
Current Assets | 683.7m |
Cash & Short-Term Investments | 192.8m |
Receivables | 446.7m |
Other Current Assets | 44.1m |
Non-Current Assets | 2B |
Long-Term Investments | 4.9m |
PP&E | 90.2m |
Intangibles | 1.9B |
Other Non-Current Assets | 33m |
Current Liabilities | 674.2m |
Accounts Payable | 48.2m |
Accrued Liabilities | 216m |
Other Current Liabilities | 410m |
Non-Current Liabilities | 759.9m |
Long-Term Debt | 597m |
Other Non-Current Liabilities | 162.9m |
Earnings Waterfall
Evolent Health Inc
Revenue
|
2B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
460.5m
USD
|
Operating Expenses
|
-447.7m
USD
|
Operating Income
|
12.8m
USD
|
Other Expenses
|
-155.1m
USD
|
Net Income
|
-142.3m
USD
|
Free Cash Flow Analysis
Evolent Health Inc
EVH Profitability Score
Profitability Due Diligence
Evolent Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Evolent Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
EVH Solvency Score
Solvency Due Diligence
Evolent Health Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Evolent Health Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EVH Price Targets Summary
Evolent Health Inc
According to Wall Street analysts, the average 1-year price target for EVH is 45.56 USD with a low forecast of 34.34 USD and a high forecast of 66.15 USD.
Ownership
EVH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
EVH Price
Evolent Health Inc
Average Annual Return | 27.47% |
Standard Deviation of Annual Returns | 52.86% |
Max Drawdown | -75% |
Market Capitalization | 3.2B USD |
Shares Outstanding | 113 893 000 |
Percentage of Shares Shorted | 10.92% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Evolent Health, Inc. engages in the provision of health care delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 3,500 full-time employees. The company went IPO on 2015-06-05. The firm supports health systems and physician organizations as well as health plans to move their business models from traditional fee-for-service reimbursement to value-based care. The firm operates through two segments: Evolent Health Services and Clinical Solutions. Its Evolent Health Services segment houses its administrative simplification solution and certain supporting population health infrastructure. Its Clinical Solutions segment includes its specialty management and physician-oriented total cost of care solutions, along with the New Century Health and Evolent Care Partners brands. The company offers solutions such as care management, specialty care management, and administrative simplification. Its New Century Health is a national population health provider in managing specialty care for medicare, commercial and medicaid members.
Contact
IPO
Employees
Officers
The intrinsic value of one EVH stock under the Base Case scenario is 34.58 USD.
Compared to the current market price of 28.32 USD, Evolent Health Inc is Undervalued by 18%.